Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€2.62

€2.62

1.500%
0.04
1.500%
-

-

 
20.01.22 / Tradegate WKN: A14SUX / Name: Adaptimmune / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
09.01.22
-13.25%
buy
08.07.21
-23.39%
buy
Your prediction

Adaptimmune Therapeutics PLC ADR Stock

There is an upward development for Adaptimmune Therapeutics PLC ADR compared to yesterday, with an increase of €0.040 (1.500%).
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Adaptimmune Therapeutics PLC ADR stock is not clear.
Our community identified positive and negative aspects for Adaptimmune Therapeutics PLC ADR stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Adaptimmune Therapeutics PLC ADR stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.

Pros and Cons of Adaptimmune Therapeutics PLC ADR in the next few years

Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Adaptimmune Therapeutics PLC ADR vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Adaptimmune Therapeutics PLC ADR 1.500% -10.884% -27.222% -45.188% -22.485% - -
4d Pharma plc 1.670% -14.286% -20.000% -65.714% -28.889% - -
Bioventix plc 1.080% -2.083% -1.571% -24.498% -5.051% - -
Clinigen Group plc 0.090% -0.284% 1.540% 30.086% -2.315% - -

Comments

Sell Adaptimmune Therapeutics PLC ADR
Show more

Other discussions about Adaptimmune Therapeutics PLC ADR Stock

Trading Adaptimmune Therapeutics PLC ADR

Trading Adaptimmune Therapeutics PLC ADR

New thread Forum